Vanesa P.
- Country
- Spain
- Department
- Pediatric oncology and hematology department
Research Overview
- Evaluation of Dexamethasone Versus Prednisone in Induction Therapy for Pediatric and Adolescent Lymphoblastic Lymphoma: A Randomized Controlled Trial
- Phase 1/2 Evaluation of Relatlimab and Nivolumab in Pediatric and Young Adult Patients with Recurrent or Refractory Classical Hodgkin and Non-Hodgkin Lymphoma
- Phase I-II Evaluation of Sunitinib and Nivolumab with Chemotherapy in Advanced Soft Tissue and Bone Sarcomas
Data & Insights
Has run more than one trial at 98 of 202 partner sites.
Specializations
Pediatric Oncology
Focused on malignancies that arise in children and adolescents, including rare and aggressive tumor types.
- Acute Lymphoblastic Leukemia
- Neuroblastoma
- Hodgkin Lymphoma
- Brain Tumors
- Pediatric Sarcomas
Research aims to improve survival and reduce long‑term toxicity in young patients.
Hematologic Malignancies
Investigation of blood‑derived cancers across age groups, emphasizing molecular subtypes and targeted strategies.
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Myelodysplastic Syndromes
- Peripheral T‑Cell Lymphoma
Efforts include biomarker‑driven enrollment and assessment of novel agents.
Advanced Solid Tumors
Broad engagement with metastatic and refractory solid cancers, often defined by specific genomic alterations.
- Non‑Small Cell Lung Cancer
- Breast Cancer
- Renal Cell Carcinoma
- Colorectal Cancer
- Neuroendocrine Tumors
Studies target pathways such as EGFR, KRAS, HER2, and PD‑L1.
Immunologic and Autoimmune Disorders
Exploration of immune‑mediated diseases where modulation of inflammatory pathways is central.
- Systemic Lupus Erythematosus
- Psoriatic Arthritis
- Atopic Dermatitis
- Inflammatory Bowel Disease
- Vasculitis
Therapeutic focus includes cytokine inhibition and cellular immune regulation.
Cardiovascular and Metabolic Diseases
Addressing high‑impact conditions that intersect with oncology and chronic inflammation.
- Atherosclerotic Cardiovascular Disease
- Heart Failure with Preserved Ejection Fraction
- Hyperlipidemia
- Diabetes‑Related Vascular Complications
- Obesity‑Associated Sleep Apnea
Investigations incorporate risk stratification and novel metabolic therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
